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Summary
FADD is a common adaptor shared by several death-receptors (DRs) for signaling apoptosis 
through recruitment and activation of caspase 81-3. DRs are essential for immune homeostasis, 
but dispensable during embryogenesis. Surprisingly, FADD−/− mice die in utero4-5 and 
conditional deletion of FADD leads to impaired lymphocyte proliferation6-7. How FADD 
regulates embryogenesis and lymphocyte responses has been a long standing enigma. FADD 
could directly bind to RIP1, a serine/threonine kinase which mediates both necrosis and NF-κB 
activation. Here we show that FADD−/− embryos contain elevated levels of RIP1 and exhibit 
massive necrosis. To investigate potential in vivo functional interaction between RIP1 and FADD, 
null alleles of RIP1 were crossed into FADD−/− mice. Strikingly, RIP1 deficiency allowed normal 
embryogenesis of FADD−/− mice. Conversely, the developmental defect of RIP1−/− lymphocytes 
was partially corrected by FADD deletion. Furthermore, RIP1 deficiency fully restored normal 
proliferation in FADD−/− T cells but not in FADD−/− B cells. FADD−/−RIP1−/− double knockout 
(DKO) T cells are resistant to death induced by Fas or TNFα and display reduced NF-κB activity. 
Therefore, our data demonstrate an unexpected cell type-specific interplay between FADD and 
RIP1, which is critical for the regulation of apoptosis and necrosis during embryogenesis and 
lymphocyte function.
Programmed cell death (PCD) including apoptosis and necrosis are fundamental biological 
processes that are essential during embryonic development and for homeostasis in somatic 
tissues. DRs can signal apoptotic cell death when engaged by their cognate ligands8. This 
extrinsic death pathway requires the adaptor protein FADD that couples the signal generated 
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by DRs to the apical caspase 83,9-10. The resulting activation of caspase 8 triggers a battery 
of downstream caspases, leading to apoptosis. Recently, DRs were shown to induce 
necrosis-like cell death in the presence of caspase inhibitors11-12. DR-induced necrosis is 
blocked in cells lacking the protein serine/threonine kinases RIP1 and RIP311-15. FADD 
and RIP1 play indispensable roles in development, as FADD−/− mice die during 
midgestation stages4-5, and RIP1−/− mice die at birth16. Whereas the developmental defect 
in RIP1−/− mice is presumably due in part to defective NF-κB activation and increased cell 
death17, the mechanism that underlies the developmental defect of FADD−/− mice has 
remained elusive.
Developmental retardation of FADD−/− mouse is apparent at embryonic day (E)11.5 to 13.5 
(Fig. S1a-b). Histological analysis revealed extensive necrotic cell death and cell loss in 
FADD−/− embryos (Fig. 1a). Absence of FADD sensitizes human Jurkat T lymphoma cells 
to tumor necrosis factor (TNF)-induced necrosis11-12. Furthermore, FADD−/− mouse 
embryonic fibroblasts (MEFs) were hypersensitive to reactive oxygen species (ROS)-
induced necrosis18. In contrast, necrosis induced by ROS was blocked in RIP1−/− MEF 
cells. Examination of wild type (WT) E12.5 embryos showed that RIP1 was expressed at 
low levels while RIP3 was readily detected in multiple tissues including the nervous system, 
heart and lung (Fig. 1a and S2). Interestingly, RIP1 expression is highly elevated in 
FADD−/− embryos (Fig. 1a). Furthermore, punctate RIP3 staining was observed in cells of 
FADD−/− embryos, which is indicative of RIP3 aggregation and activation14. These results 
indicate that induction of RIP1 expression might play a role in the necrosis observed in 
FADD−/− embryos.
To investigate a potential in vivo molecular interplay between FADD- and RIP1-mediated 
signaling, we crossed the RIP1 knockout alleles into FADD−/− mice. Strikingly, 
FADD−/−RIP1−/− double knockout (DKO) embryos were detected at E14.5 at the expected 
Mendelian frequencies (Table 1, Fig. 1b and S1c-f). In sharp contrast to the highly deformed 
E14.5 FADD−/− embryos, E14.5 DKO embryos were indistinguishable from wild type 
control embryos (Fig. 1b). DKO embryos of normal morphology were also found at later 
gestation stages E15.5, E16.5, E17.5 and E18.5 at the expected Mendelian frequencies (Fig. 
S1c and Table 1). Importantly, live DKO neonates were also detected at birth (Fig. S1d). No 
FADD−/− embryos were detected at E15.5 or later stages. Histological examination did not 
reveal obvious defects in RIP1−/− and DKO E18.5 embryos (Fig. S3). Postnatal monitoring 
was performed to determine the survival of DKO mice. Among the 104 postnatal mice 
analyzed (>0 day, Table 1), 30 died within 4 days after birth, which contain 6 DKO and 19 
RIP1−/− genotypes. No death was observed after postnatal day 4 and DKO mice were not 
present in the remaining 74 mice that survive beyond 3 weeks (Table 1). These results 
demonstrate that RIP1 deficiency fully restore embryonic development of FADD−/− mice. 
However, loss of FADD does not prevent neonatal lethality of RIP1−/− mice. ROS is an 
important effector mechanism for necrotic cell death. FADD−/− MEFs were hypersensitive 
to ROS-induced death (Fig. S4a-b). In contrast, RIP1−/− MEFs were highly resistant to 
ROS-induced necrosis18. Addition of the RIP1-specific inhibitor necrostatin-1 (Nec-1)19 
greatly reduced ROS-hypersensitivity in FADD−/− MEFs (Fig. S4a-b). Importantly, DKO 
MEFs were resistant to ROS-induced death. Collectively, these results indicate that FADD 
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deficiency primes embryonic cells to ROS- and RIP1-dependent necrosis, which might 
cause embryonic lethality.
While important at early hematopoietic stages 20, FADD plays a minor role in post lineage 
commitment lymphopoiesis 4,6-7. Although RIP1−/− neonates contain normal thymocyte 
numbers16, RIP1−/− fetal liver cells failed to reconstitute the peripheral T cell 
compartment17. The rescue of embryonic development in DKO mice prompted us to 
examine whether a similar FADD-RIP1 interaction might regulate lymphocyte development. 
To this end, we adoptively transferred fetal liver cells containing hematopoietic progenitor 
cells into immunodeficient NSG recipient mice. In agreement with previous results17, NSG 
chimeras reconstituted with RIP1−/− fetal liver cells contained dramatically reduced 
CD4+CD8+ double positive immature and CD4+ or CD8+ single positive mature thymocytes 
(Fig. 2a). In contrast, the thymic population profile of DKO fetal liver cell chimeras was 
similar to that of the wild type control thymus (Fig. 2a). Reconstitution of the peripheral 
lymphoid compartment by DKO fetal liver cells was apparent, as indicated by the spleen 
sizes of the recipients of DKO fetal liver cells, which was similar to the size of the control 
spleens receiving wild type fetal liver cells (Fig. S5a). In contrast, the spleen of RIP1−/− 
chimeras was smaller than that of wild type or DKO chimeras. Flow cytometric analyses 
showed that RIP1−/− chimeras contained few CD3+ T cells in the periphery (Fig. 2b and 
S5b-c). In contrast, DKO chimeras contained significantly higher numbers of T cells in the 
spleen, lymph nodes, and blood (Fig. 2b and S5b-c). Similarly, FADD deficiency partially 
rescued RIP1−/− B cell development (Fig. S5c). RIP1−/− thymocytes were readily killed by 
treatments with anti-Fas antibodies or TNF (Fig. 2c-d). Interestingly, DKO thymocytes were 
highly resistant to these death stimuli. Although FADD deficiency fully reversed the 
hypersensitivity to Fas- and TNFα-induced killing, it only partially corrected the NF-κB 
activation defect in RIP1−/− T cells, B cells and MEFs (Fig. 2e-g). These results suggest that 
the partial rescue of lymphocyte development in the DKO chimeras is due to inhibition of 
FADD-mediated apoptosis rather than rescue of NF-κB activation.
Although T cell-specific deletion of FADD had no effect on thymic development, the 
resulting mature FADD−/− T cells were highly defective in TCR-induced proliferation6 (Fig. 
3a). When compared to FADD−/− and WT controls, DKO T cells stimulated through the 
TCR/CD28 exhibited a remarkable rescue in their proliferative responses (Fig. 3a and Table 
S1a). When transferred to TCRαβ−/− hosts, DKO T cells were functionally competent to 
expand and produce IFNγ in response to challenge with Pichinde virus (PV) (Fig. 3b). Acute 
CD8+ T cell responses to the immunodominant epitope NP38 and subdominant epitope 
NP205 were similar between WT and DKO donor cells (Fig. 3b). Moreover, challenge of 
wild type hosts adoptively transferred with DKO lymphocytes with lymphocytic 
choriomenigitis virus (LCMV) showed that the DKO T cells could generate a productive 
anti-viral response to the immunodominant epitope NP396 (Fig. S6a). Collectively, these 
results indicate that RIP1-dependent necrosis underlies the defective proliferation in 
FADD−/− T cells and that inactivation of RIP1 restores the proliferative capacity of 
FADD−/− T cells.
Although FADD does not play a significant role in BCR- or CD40-induced proliferation 
responses, it is required for TLR3 and TLR4 signaling in B cells7. Consistent with these 
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observations, WT, RIP1−/−, FADD−/− and DKO B cells responded similarly to stimulation 
with anti-IgM or anti-CD40 antibodies (Fig. S6b and data not shown). In contrast to the 
rescue of T cell proliferation, DKO B cells remained defective in proliferative responses to 
the TLR3 and TLR4 agonists poly IC and LPS, respectively (Fig. 3c, S6c and Table S1b). 
The differential effect of RIP1 deletion on FADD−/− T and B cell proliferation was 
confirmed with the RIP1-specific inhibitor Nec-1 (Fig. S6d-e). Although caspase inhibition 
did hamper LPS-induced B cell proliferation (Fig. S7a-b), RIP1 cleavage, which inactivates 
the pro-necrotic activity of RIP1, was only observed in TCR-treated T cells, but not LPS-
induced B cells or ROS-treated MEFs (Fig. S8a-c). Therefore, the FADD-RIP1 axis is 
preferentially required for controlling proliferation in T cells, but not in B cells.
The current study demonstrates that absence of RIP1 restored normal embryogenesis of 
FADD−/− mice, and FADD deficiency partially corrects the developmental defect in RIP1−/− 
T cells. This finding provides compelling genetic evidence that a critical in vivo role for 
FADD during embryogenesis is to inhibit RIP1-mediated necrosis. In T cells, RIP1 is 
required to help suppress FADD-mediated apoptosis. Interestingly, caspase 8−/− mice 
exhibited embryonic and T cell defects similar to that of FADD−/− mice4-5,21. Moreover, 
Nec-1 rescued the proliferative defect of caspase 8−/− and FADD−/− T cells22-23. Hence, 
FADD and caspase 8 likely act in concert to keep RIP1-mediated necrosis in check by 
cleavage and inactivation of RIP1. Such regulatory mechanism is crucial to ensure proper 
embryogenesis and to prevent abortive expansion of T cells during immune responses. Our 
results also reveal an unexpected role for RIP1 to keep FADD-mediated apoptosis at bay 
during T cell development. This regulation is not entirely dependent on RIP1-mediated 
activation of the NF-κB pathways, unlike that proposed previously16-17. The reduced NF-
κB activation had no major effect on DKO T cell proliferations. In addition to lymphocytes, 
impairment of the NF-κB pathway is also present in RIP1−/− and DKO MEFs and likely 
other cell types, which might lead to postnatal lethality as seen in RIP1−/− and DKO mice. In 
summary, our results reveal a complex functional interaction between FADD and RIP1 that 
is context- and cell type-dependent.
Methods summary
Heterozygous FADD+/− mutant mice have been described4. Heterozygous RIP1+/− 
mutant mice16 were provided by Dr. M. Kelliher and crossed into FADD+/− mice. Timed 
pregnancy was set up with the resulting FADD+/−RIP1+/− mouse intercrosses. Embryos 
were isolated and genotyped by PCR using tissue genomic DNA templates and 
confirmed by western blots. Fetal liver cells were isolated from E14.5 embryos and 
adoptively transferred into irradiated (200 RAD) NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/
SzJ) mice purchased from The Jackson Laboratory. All animal studies were approved by 
Institutional Animal Care and Use Committees. Ten to 12 weeks post transfer, cells were 
isolated from the indicated organs and were analyzed by flow cytometry. T cells and B 
cells were purified from the spleen and lymph nodes by high-speed sorting and 
proliferative responses were analyzed as described previously6-7. FADD−/− mutant T 
cells and B cells were isolated by sorting from T cell-specific and B cell-specific 
FADD−/− mice as described previously6-7. Western blotting was performed according to 
standard protocols. For embryonic cell death assays, primary MEFs were prepared 
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following the NIH 3T3 protocol. FADD−/− MEFs were prepared from E8.5 embryos and 
DKO MEFs from E14.5MEFs. MEF cells were cultured in complete DMEM to 80% 
confluence, and treated with 0.5 mM H2O2 with or without Nec-1 (50 μM) for 12 h, and 
cell death was determined by propidium iodide staining and flow cytometry. Images were 
taken by using a Nikon inverted light microscope. For virus infections, after adoptive 
transfer of lymphocytes, mice were challenged with 5 × 104 pfu of LCMV or 1 × 107 pfu 
of PV. Peptide specific CD8 T cell responses were measured 8 days after infection by 
intracellular IFNγ staining.
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Appendix
Online-only Methods
Reagents
Antibodies were purchased from the following vendors: RIP1 (BD Pharmingen), RIP3 
(ProSci), caspase 8 (Axxora), phospho-p65 (Cell Signaling), CD3 (BD Biosciences), CD28 
(BD Biosciences), and strepavidin (BD Biosciences). Antibodies used in 
immunophenotyping were purchased from BD Biosciences or eBioscience or BioLegend. 
Rabbit anti-FADD antibody were generated in house. Necrostatin-1 and zVAD-fmk were 
purchased from Axxora.
Mouse genetic analysis
Mating of FADD+/−RIP1+/− double heterozygous mice was set up at evening. Female mice 
were examined in the early morning and embryos were designated E0.5 on the day the 
vaginal plug was detected. E11.5 to E18.5 embryos were isolated from pregnant mice and 
genomic DNA was extracted from embryo tissues upon digestion with protease K in an SDS 
containing lysis buffer. Genotyping was performed by PCR using allele-specific primers. 5′-
TGCGCCGACACGATCTACTG-3′ and 5′-AGCTGTAGGCTTGTCAGGGTGTTTC -3′ 
were used for the detection of the FADD wild type allele; 5′-
ACTGTAGTGCCCAGCAGAGACCAGC -3′ and 5′-
CGCTCGGTGTTCGAGGCCACACGC -3′ for the FADD knock out allele; 5′-
TGTGTCAAGTCTCCCTGCAG-3′ and 5′-CACGGTCCTTTTGCCCTG-3 for the RIP1 WT 
allele; and 5′-CTGCTAAAGCGCATGCTC-3′ and 5′-CACGGTCCTTTTGCCCTG-3 for 
the RIP1 knock out allele. Presence and absence of the FADD and RIP1 protein was 
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confirmed by western blotting using anti-FADD and anti-RIP1 (BD Pharmingen) antibodies. 
For postnatal analysis, pregnant females were closely monitored around the time of delivery 
(after 18.5 days post coitum), by checking at least twice daily. Neonates were either 
euthanized at birth for genotyping or monitored for survival up to 6 months. Dead mice were 
immediately removed for genotyping.
Histological analysis and immunohistochemistry
Embryos were fixed in 10% buffered formalin overnight. After dehydration in 70% and 
increasing concentrations of ethanol, embryos were embedded in paraffin. Embryo sections 
were prepared and standard H&E staining performed. Immunohistochemistry was 
performed using anti-RIP1 (H207, Santa Cruz) and anti-RIP3 (ProSci) antibodies at 1:200 
dilution, followed by incubation with ImmPress anti-rabbit peroxidase (Vector Lab). Signals 
were developed with 3,3′-Diaminobenzidine (5 min) and Enhancer (DAKO) for 2 min. 
Sections were then counterstained with hematoxylin.
Lymphocyte immunophenotyping
Lymphocytes were isolated from spleen, thymus, lymphocyte nodes and blood. Red blood 
cells were lysed using the ACK lysis buffer and single cell suspension was prepared, stained 
for cell surface markers following standard protocols, and data acquisition was performed 
using a Coulter XL cytometer. Flow cytometric data were analyzed with the FlowJo 
software (Treestar, San Carlos, CA).
Cell death analysis
Thymocytes were isolated from the E18.5 embryos and resuspended in RPMI 1640 medium 
containing 10% fetal bovine serum and antibiotics. Cells were then seeded (1 × 105/well) 
into 96-well flat bottom plates with various concentrations of anti-Fas antibodies (Jo2; BD 
Pharmingen) or recombinant mouse TNF-α (Biosource/Invitrogen) in the presence of 30 
μg/ml cycloheximide (Sigma-Aldrich). Cell death was determined by propidium iodide (PI) 
staining and flow cytometry 12-16 h post stimulation.
Lymphocyte activation and western blot analysis
Peripheral T cells and B cells were purified from the spleen and lymphoid nodes using 
EasySep Isolation reagent (StemCell Technologies) or high speed sorting. Purified T cells 
were stimulated with biotinylated anti-CD3 antibodies (10μg/ml) and anti-CD28 antibodies 
(2 μg/ml) by crosslinking with streptavidin (10 μg/ml) for the indicated times at 37 °C. In 
some experiments, cells were stimulated with plate-bound anti-CD3 and anti-CD28 
antibodies. Purified B cells were stimulated with 10 μg/ml LPS for the indicated times at 
37°C. Where indicated, cells were pre-incubated with 50 μM zVAD-fmk or 10 μM 
necrostatin-1 before stimulation. Cells were washed once in ice cold PBS and lysed with ice-
cold RIPA lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet 
P-40, 0.5% deoxycholate, 0.1% SDS, 1 mM phenylmethyl sulfonyl fluoride (PMSF) and a 
protease inhibitor cocktail (Roche). Protein was separated on 10% SDS/PAGE then 
transferred onto nitrocellulose membrane, blocked with 5% milk in TBST, incubated 
overnight at 4°C with primary Abs. Blots were washed 3 times with TBST and incubated in 
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HRP-conjugated second antibody per manufacturer’s recommendations. The Western 
Lighting Chemiluminescence Reagent Plus (PerkinElmer) or ThermoScientific West Pico 
chemiluminescence reagents were used to detect signals on x-ray films (Kodak).
Cell culture and proliferation assays
Purified T cells and B cells were cultured in RPMI 1640 (Mediatech, Herndon, VA) 
supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 1mM glutamine, 5 μM β-
mercaptoethanol (Sigma, St. Louis, MO), and 10% FBS (HyClone Laboratories, Logan, 
UT). Cells were cultured at 37 °C in a 5% CO2 incubator. B cells were cultured with the 
indicated concentrations of LPS, poly IC (Sigma-Aldrich, St. Louis, MO), goat-anti-mouse 
IgM (F(ab’)2 μ chain, Jackson ImmunoResearch, West Grove, PA) for 48 h. T cells were 
stimulated with various concentration of plate-bound anti-CD3 antibodies in 96 well plates 
in the presence of anti-CD28 (200ng/ml) antibodies for 48 hours. Incorporated [3H]-
thymidine was measured using a Wallac beta counter (PerkinElmer, Wellesley, MA). To 
determine cell division, cell proliferation measured by dilution of CellTracer Violet dye 
(Invitrogen) was performed as per the manufacturer’s instructions.
Virus infection
Ten to twenty millions wild type or DKO total splenocytes were injected via the tail vein to 
wild type Ly5.1 congenic hosts. For injection into TCRαβ−/− hosts, 2 × 106 cells were 
injected. Eighteen hours later, mice were infected with 5 × 104 pfu of lymphocytic 
choriomenigitis virus (Armstrong strain) or 1 × 107 pfu of Pichinde virus (strain AN3739) 
intraperitoneally. Eight days post-infection, splenocytes were isolated and stimulated with 
the indicated viral peptide antigens for 5 hours or anti-CD3 antibody for 4 hours. Production 
of IFNγ was examined by intracellular FACS staining on a LSRII flow cytometer (BD 
Biosciences).
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Figure 1. RIP1 deficiency rescues FADD−/− mice from embryonic necrosis and lethality
a, FADD−/− embryos exhibit massive necrosis and altered RIP1 and RIP3 expression. E12.5 
wild type (WT, top panels) or FADD−/− embryos (bottom panels) were fixed in formalin. 
Left panels of hematoxylin and eosin (H&E) staining show extensive cell loss and pyknotic 
nuclei in the FADD−/− fetal liver. Middle and right panels indicate staining for RIP1or RIP3. 
b, E14.5 DKO embryos appear normal, contrasting the defective FADD−/− embryos.
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Figure 2. FADD deficiency partially corrects the RIP1−/− T cell developmental defect by 
blocking apoptosis
Lymphocytes (a-b) in the chimeras of the indicated genotypes were analyzed. E18.5 fetal 
thymocytes of the indicated genotypes were treated with anti-Fas antibodies (c) or TNFα (d) 
and death responses determined 12 hours post stimulation. Error bars represent mean ± SEM 
of triplicates. T cells (e) and B cells (f) from NSG chimeras of the indicated genotypes were 
stimulated with anti-CD3 and anti-CD28 antibodies or with LPS, respectively. MEFs were 
stimulated with TNFα (g). NF-κB activation was indicated by the induction of p65 
phosphorylation. β-actin, loading controls.
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Figure 3. RIP1 deficiency rescues the FADD−/− T cell proliferation defect
a, T cells of the indicated wild type and chimera genotypes were stimulated with anti-CD3 
and anti-CD28 antibodies. Proliferation was measured by [3H]-thymidine incorporation. b, 
Splenocytes of the indicated genotypes were transferred into TCRαβ−/− hosts and challenged 
with Pichinde virus (PV). Acute responses of the donor CD8 T cells to the indicated 
epitopes were determined. Anti-CD3 antibodies were used as control. c, B cells of the 
indicated genotypes were stimulated with LPS and proliferation was measured as in (a). 
Results shown (a and c) are mean ± SEM of triplicates.
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